Literature DB >> 35616095

Generation of novel SARS-CoV-2 variants on B.1.1.7 lineage in three patients with advanced HIV disease.

Anna C Riddell1, Beatrix Kele1, Kathryn Harris1, Jon Bible1, Maurice Murphy2, Subathira Dakshina2, Nathaniel Storey3, Dola Owoyemi1, Corinna Pade4, Joseph M Gibbons4, David Harrington1, Eliza Alexander1, Áine McKnight4, Teresa Cutino-Moguel1.   

Abstract

The emergence of new SARS-COV-2 variants is of public health concern in case of vaccine escape. Described are three patients with advanced HIV-1 and chronic SARS-CoV-2 infection in whom there is evidence of selection and persistence of novel mutations which are associated with increased transmissibility and immune escape.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  B.1.1.7; HIV-1 infection; SARS CoV-2; alpha variant; immunocompromised

Year:  2022        PMID： 35616095      PMCID： PMC9213850          DOI： 10.1093/cid/ciac409

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   20.999


  16 in total

Review 1.  T Follicular Helper Cell Biology: A Decade of Discovery and Diseases.

Authors:  Shane Crotty
Journal:  Immunity       Date:  2019-05-21       Impact factor: 31.745

2.  Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival.

Authors:  Stefania Dispinseri; Massimiliano Secchi; Maria Franca Pirillo; Monica Tolazzi; Martina Borghi; Cristina Brigatti; Maria Laura De Angelis; Marco Baratella; Elena Bazzigaluppi; Giulietta Venturi; Francesca Sironi; Andrea Canitano; Ilaria Marzinotto; Cristina Tresoldi; Fabio Ciceri; Lorenzo Piemonti; Donatella Negri; Andrea Cara; Vito Lampasona; Gabriella Scarlatti
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

3.  The basis of a more contagious 501Y.V1 variant of SARS-CoV-2.

Authors:  Haolin Liu; Qianqian Zhang; Pengcheng Wei; Zhongzhou Chen; Katja Aviszus; John Yang; Walter Downing; Chengyu Jiang; Bo Liang; Lyndon Reynoso; Gregory P Downey; Stephen K Frankel; John Kappler; Philippa Marrack; Gongyi Zhang
Journal:  Cell Res       Date:  2021-04-23       Impact factor: 25.617

4.  SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms.

Authors:  Sarah A Clark; Lars E Clark; Junhua Pan; Adrian Coscia; Lindsay G A McKay; Sundaresh Shankar; Rebecca I Johnson; Vesna Brusic; Manish C Choudhary; James Regan; Jonathan Z Li; Anthony Griffiths; Jonathan Abraham
Journal:  Cell       Date:  2021-03-16       Impact factor: 41.582

5.  Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose.

Authors:  Catherine J Reynolds; Corinna Pade; Joseph M Gibbons; Áine McKnight; Daniel M Altmann; Rosemary Boyton; David K Butler; Ashley D Otter; Katia Menacho; Marianna Fontana; Angelique Smit; Jane E Sackville-West; Teresa Cutino-Moguel; Mala K Maini; Benjamin Chain; Mahdad Noursadeghi; Tim Brooks; Amanda Semper; Charlotte Manisty; Thomas A Treibel; James C Moon; Ana M Valdes
Journal:  Science       Date:  2021-04-30       Impact factor: 63.714

6.  SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.

Authors:  Petra Mlcochova; Steven A Kemp; Mahesh Shanker Dhar; Partha Rakshit; Anurag Agrawal; Ravindra K Gupta; Guido Papa; Bo Meng; Isabella A T M Ferreira; Rawlings Datir; Dami A Collier; Anna Albecka; Sujeet Singh; Rajesh Pandey; Jonathan Brown; Jie Zhou; Niluka Goonawardane; Swapnil Mishra; Charles Whittaker; Thomas Mellan; Robin Marwal; Meena Datta; Shantanu Sengupta; Kalaiarasan Ponnusamy; Venkatraman Srinivasan Radhakrishnan; Adam Abdullahi; Oscar Charles; Partha Chattopadhyay; Priti Devi; Daniela Caputo; Tom Peacock; Chand Wattal; Neeraj Goel; Ambrish Satwik; Raju Vaishya; Meenakshi Agarwal; Antranik Mavousian; Joo Hyeon Lee; Jessica Bassi; Chiara Silacci-Fegni; Christian Saliba; Dora Pinto; Takashi Irie; Isao Yoshida; William L Hamilton; Kei Sato; Samir Bhatt; Seth Flaxman; Leo C James; Davide Corti; Luca Piccoli; Wendy S Barclay
Journal:  Nature       Date:  2021-09-06       Impact factor: 49.962

7.  Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.

Authors:  Alba Grifoni; Daniela Weiskopf; Sydney I Ramirez; Jose Mateus; Jennifer M Dan; Carolyn Rydyznski Moderbacher; Stephen A Rawlings; Aaron Sutherland; Lakshmanane Premkumar; Ramesh S Jadi; Daniel Marrama; Aravinda M de Silva; April Frazier; Aaron F Carlin; Jason A Greenbaum; Bjoern Peters; Florian Krammer; Davey M Smith; Shane Crotty; Alessandro Sette
Journal:  Cell       Date:  2020-05-20       Impact factor: 66.850

8.  Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer.

Authors:  Victoria A Avanzato; M Jeremiah Matson; Stephanie N Seifert; Rhys Pryce; Brandi N Williamson; Sarah L Anzick; Kent Barbian; Seth D Judson; Elizabeth R Fischer; Craig Martens; Thomas A Bowden; Emmie de Wit; Francis X Riedo; Vincent J Munster
Journal:  Cell       Date:  2020-11-04       Impact factor: 41.582

9.  Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient.

Authors:  Ji Hoon Baang; Christopher Smith; Carmen Mirabelli; Andrew L Valesano; David M Manthei; Michael A Bachman; Christiane E Wobus; Michael Adams; Laraine Washer; Emily T Martin; Adam S Lauring
Journal:  J Infect Dis       Date:  2021-01-04       Impact factor: 5.226
View more
  4 in total

1.  Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Shedding in a Patient With AIDS: Case Report and Review of the Literature.

Authors:  Jillian L Peters; Amary Fall; Steven D Langerman; Margueritta El Asmar; Mari Nakazawa; Aishat Mustapha; Aaron A R Tobian; Heba H Mostafa; Joel N Blankson
Journal:  Open Forum Infect Dis       Date:  2022-09-17       Impact factor: 4.423

2.  Persistent infection with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in a patient with untreated human immunodeficiency virus (HIV).

Authors:  Alice Zhabokritsky; Samira Mubareka; Robert A Kozak; Finlay Maguire; Lily Yip; Paul Yip; Jeff Powis
Journal:  Infect Control Hosp Epidemiol       Date:  2022-05-20       Impact factor: 6.520

3.  Recurrent SARS-CoV-2 mutations in immunodeficient patients.

Authors:  S A J Wilkinson; Alex Richter; Anna Casey; Husam Osman; Jeremy D Mirza; Joanne Stockton; Josh Quick; Liz Ratcliffe; Natalie Sparks; Nicola Cumley; Radoslaw Poplawski; Samuel N Nicholls; Beatrix Kele; Kathryn Harris; Thomas P Peacock; Nicholas J Loman
Journal:  Virus Evol       Date:  2022-08-11

4.  Selection Analysis Identifies Clusters of Unusual Mutational Changes in Omicron Lineage BA.1 That Likely Impact Spike Function.

Authors:  Darren P Martin; Spyros Lytras; Alexander G Lucaci; Wolfgang Maier; Björn Grüning; Stephen D Shank; Steven Weaver; Oscar A MacLean; Richard J Orton; Philippe Lemey; Maciej F Boni; Houriiyah Tegally; Gordon W Harkins; Cathrine Scheepers; Jinal N Bhiman; Josie Everatt; Daniel G Amoako; James Emmanuel San; Jennifer Giandhari; Alex Sigal; Carolyn Williamson; Nei-Yuan Hsiao; Anne von Gottberg; Arne De Klerk; Robert W Shafer; David L Robertson; Robert J Wilkinson; B Trevor Sewell; Richard Lessells; Anton Nekrutenko; Allison J Greaney; Tyler N Starr; Jesse D Bloom; Ben Murrell; Eduan Wilkinson; Ravindra K Gupta; Tulio de Oliveira; Sergei L Kosakovsky Pond
Journal:  Mol Biol Evol       Date:  2022-04-11       Impact factor: 8.800
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.